SI2152868T1 - Sestavki prokariotske fenilalanin amonijakove liaze in postopki za uporabo navedenih sestavkov - Google Patents

Sestavki prokariotske fenilalanin amonijakove liaze in postopki za uporabo navedenih sestavkov

Info

Publication number: SI2152868T1
Authority: SI; Slovenia
Prior art keywords: compositions; lyase; methods; phenylalanine ammonia; prokaryotic phenylalanine
Prior art date: 2007-05-25

Application number

SI200831540T

Other languages

English (en)

Inventor

Michel C. Vellard

Paul A. Fitzpatrick

Emil D. Kakkis

Daniel J. Wendt

Original Assignee

Biomarin Pharmaceutical Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-25

Filing date

2008-05-23

Publication date

2015-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39868905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2152868(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-05-23 Application filed by Biomarin Pharmaceutical Inc. filed Critical Biomarin Pharmaceutical Inc.

2015-12-31 Publication of SI2152868T1 publication Critical patent/SI2152868T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Obesity (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SI200831540T 2007-05-25 2008-05-23 Sestavki prokariotske fenilalanin amonijakove liaze in postopki za uporabo navedenih sestavkov SI2152868T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/807,227 US7534595B2 (en)	2006-06-12	2007-05-25	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
PCT/US2008/006661 WO2008153776A1 (en)	2007-05-25	2008-05-23	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using said compositions
EP08754717.0A EP2152868B1 (en)	2007-05-25	2008-05-23	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using said compositions

Publications (1)

Publication Number	Publication Date
SI2152868T1 true SI2152868T1 (sl)	2015-12-31

Family

ID=39868905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200831540T SI2152868T1 (sl)	2007-05-25	2008-05-23	Sestavki prokariotske fenilalanin amonijakove liaze in postopki za uporabo navedenih sestavkov

Country Status (29)

Country	Link
US (1)	US7534595B2 (sl)
EP (2)	EP2657335A1 (sl)
JP (1)	JP5670183B2 (sl)
KR (2)	KR20150038753A (sl)
CN (1)	CN101842482B (sl)
AR (2)	AR066716A1 (sl)
AU (1)	AU2008263190B2 (sl)
BR (1)	BRPI0811267B8 (sl)
CA (1)	CA2687450C (sl)
CL (1)	CL2008001497A1 (sl)
CY (2)	CY1116894T1 (sl)
DK (1)	DK2152868T3 (sl)
EA (1)	EA018443B1 (sl)
ES (1)	ES2551315T3 (sl)
HR (1)	HRP20151268T1 (sl)
HU (2)	HUE025784T2 (sl)
IL (1)	IL202132A (sl)
LT (1)	LTC2152868I2 (sl)
LU (1)	LUC00133I2 (sl)
MX (1)	MX2009012453A (sl)
MY (1)	MY151413A (sl)
NL (1)	NL301011I2 (sl)
NO (1)	NO2019037I1 (sl)
PE (1)	PE20090315A1 (sl)
PL (1)	PL2152868T3 (sl)
PT (1)	PT2152868E (sl)
SI (1)	SI2152868T1 (sl)
TW (1)	TWI418633B (sl)
WO (1)	WO2008153776A1 (sl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7531341B1 (en)	2006-06-12	2009-05-12	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7534595B2 (en) *	2006-06-12	2009-05-19	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7537923B2 (en)	2007-08-17	2009-05-26	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
US20110201022A1 (en) *	2008-07-30	2011-08-18	Biomarin Pharmaceutical Inc.	Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
SI3025728T1 (sl) *	2010-02-04	2018-11-30	Biomarin Pharmaceutical Inc.	Metoda za čiščenje prokariontskih fenilalanin amonij-liaznih variant
EP3222288A1 (en) *	2012-07-27	2017-09-27	University of North Texas	Genetically modified probiotic for the treatment of phenylketonuria (pku) disease
ES2890955T3 (es)	2013-04-18	2022-01-25	Codexis Inc	Polipéptidos de fenilalanina amoníaco liasa modificados
BR112016011195A2 (pt) *	2013-11-18	2017-09-19	Rubius Therapeutics Inc	Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
US10869898B2 (en)	2014-04-01	2020-12-22	Rubius Therapeutics, Inc.	Methods and compositions for immunomodulation
CA2943432A1 (en)	2014-04-16	2015-10-22	Codexis, Inc.	Engineered tyrosine ammonia lyase
AU2015370125B2 (en)	2014-12-22	2022-02-03	Codexis, Inc.	Human alpha-galactosidase variants
TW202440903A (zh) *	2015-08-04	2024-10-16	美商再生元醫藥公司	補充牛磺酸之細胞培養基及用法（一）
MX2019000962A (es)	2016-07-26	2019-08-01	Biomarin Pharm Inc	Novedosas proteinas de la capside del virus adenoasociado.
ES2903263T3 (es) *	2016-08-30	2022-03-31	Mitsubishi Chem Corp	Método para producir enzima mutante y alcohol aciltransferasa mutante
CN106497905A (zh) *	2016-12-14	2017-03-15	江南大学	一株鱼腥藻来源的苯丙氨酸脱氨酶的突变体
KR102573324B1 (ko) *	2017-02-13	2023-08-30	코덱시스, 인코포레이티드	조작된 페닐알라닌 암모니아 리아제 폴리펩티드
CN107653275A (zh) *	2017-10-30	2018-02-02	安徽工程大学	D‑苯丙氨酸的制备方法
CN108004225B (zh) *	2017-12-19	2020-05-08	江南大学	一种成团泛菌来源的苯丙氨酸氨基变位酶的突变体
WO2019217513A2 (en)	2018-05-09	2019-11-14	Biomarin Pharmaceutical Inc.	Methods of treating phenylketonuria
TW202005978A (zh)	2018-05-14	2020-02-01	美商拜奧馬林製藥公司	新穎肝靶向腺相關病毒載體
EP3807409A4 (en) *	2018-06-12	2022-08-03	Codexis, Inc.	Engineered tyrosine ammonia lyase
US11198861B2 (en) *	2018-07-12	2021-12-14	Codexis, Inc.	Engineered phenylalanine ammonia lyase polypeptides
JP2022513199A (ja)	2018-12-14	2022-02-07	コデクシス，インコーポレイテッド	操作されたチロシンアンモニアリアーゼ
JP2022515742A (ja)	2018-12-20	2022-02-22	コデクシス，インコーポレイテッド	α－ガラクトシダーゼバリアント
CN110456056A (zh) *	2019-07-22	2019-11-15	浙江大学	一种新生儿苯丙酮尿症无创筛查试纸的制备方法
JP7699107B2 (ja)	2019-08-30	2025-06-26	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	操作されたリパーゼ改変体
KR20220129547A (ko)	2019-12-20	2022-09-23	코덱시스, 인코포레이티드	조작된 산성 알파-글루코시다제 변이체
BR112022015139A2 (pt)	2020-02-04	2022-10-11	Codexis Inc	Polipeptídeo da leucina descarboxilase engenheirada, composição, sequência de polinucleotídeo engenheirado, vetor de expressão, célula hospedeira, métodos para produzir um polipeptídeo da leucina descarboxilase engenheirada e para tratar e/ou prevenir os sintomas de doença da urina de xarope de bordo, composição, e, uso
WO2021168060A1 (en) *	2020-02-19	2021-08-26	Trustees Of Tufts College	Methods for engineering amino acid ammonia lyase enzymes and enzymes thereby obtained
AR122409A1 (es)	2020-04-03	2022-09-07	Biomarin Pharm Inc	Tratamiento de la fenilcetonuria con aav y formulaciones terapéuticas
CA3191900A1 (en)	2020-08-28	2022-03-03	Codexis, Inc.	Engineered amylase variants
JP2023539632A (ja)	2020-08-28	2023-09-15	コデクシス，インコーポレイテッド	操作されたプロテアーゼバリアント
US11918633B2 (en) *	2021-05-19	2024-03-05	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating adolescent subjects
TW202313969A (zh)	2021-05-21	2023-04-01	美商克迪科思股份有限公司	經工程化的甲硫胺酸γ解離酶變異體
WO2023044381A1 (en) *	2021-09-16	2023-03-23	Arcturus Therapeutics, Inc.	Compositions and methods for treating phenylketonuria
CN117417925A (zh) *	2022-07-18	2024-01-19	浙江泽科塔生物医药有限公司	Pal变体、包含该pal变体的药物组合物以及用于制备该pal变体的方法
CN118931888A (zh) *	2023-05-09	2024-11-12	重庆派金生物科技有限公司	苯丙氨酸裂解酶突变体及其偶联物或其药学上可接受的盐
GB202307239D0 (en)	2023-05-15	2023-06-28	Evox Therapeutics Ltd	Gene therapies for Phenylketonuria
CN116478975B (zh) *	2023-06-16	2023-09-01	苏州优信合生技术有限公司	高活性苯丙氨酸解氨酶突变体及其表达菌株
US20250161466A1 (en)	2023-11-17	2025-05-22	Biomarin Pharmaceutical Inc.	Conjugates of phenylalanine ammonia-lyase and poegma and methods for their use

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4252822A (en) *	1979-12-26	1981-02-24	Children's Hospital Medical Center	Method for treating phenylketonuria
US4562151A (en) *	1983-09-06	1985-12-31	Monsanto Company	Stabilization of L-phenylalanine ammonia-lyase enzyme
US5206344A (en) *	1985-06-26	1993-04-27	Cetus Oncology Corporation	Interleukin-2 muteins and polymer conjugation thereof
US5166322A (en)	1989-04-21	1992-11-24	Genetics Institute	Cysteine added variants of interleukin-3 and chemical modifications thereof
US5766897A (en) *	1990-06-21	1998-06-16	Incyte Pharmaceuticals, Inc.	Cysteine-pegylated proteins
DE69332357T2 (de) *	1992-11-19	2003-06-18	Anticancer Inc., San Diego	Verwendung von methioninase als antitumormittel in der antimethionin-chemotherapie
ATE361984T1 (de) *	1992-12-04	2007-06-15	Me Medical Enzymes Ag	Gentechnologisch hergestellte glutaminase und ihre verwendung in therapie
DK75593D0 (sl) *	1993-06-25	1993-06-25	Novo Nordisk As
AU702323B2 (en) *	1994-03-15	1999-02-18	Selective Genetics, Inc.	Heparin-binding growth factors for gene therapy and anterior eye disorders
CA2658039A1 (en) *	1995-09-21	1997-03-27	Genentech, Inc.	Human growth hormone variants
CU22585A1 (es) *	1995-11-17	1999-11-03	Centro Inmunologia Molecular	Anticuerpos monoclonales antiidiótipos (ab2) de tipo igg con alta conectividad idiotípica y composiciones farmacéuticas que los contienen. su uso como inmunoreguladores de la respuesta inmune.
US6548644B1 (en) *	1997-03-10	2003-04-15	Immunex Corporation	Site protected protein modification
US6183738B1 (en) *	1997-05-12	2001-02-06	Phoenix Pharamacologics, Inc.	Modified arginine deiminase
US5981239A (en) *	1997-09-24	1999-11-09	Great Lakes Chemical Corp.	Synthesis of optically active phenylalanine analogs using Rhodotorula graminis
EP1042459A4 (en) *	1997-12-24	2003-07-23	Diatech Pty Ltd	BIFUNCTIONAL MOLECULES
TWI227241B (en) *	1998-06-20	2005-02-01	United Biomedical Inc	IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6451986B1 (en) *	1998-06-22	2002-09-17	Immunex Corporation	Site specific protein modification
US6461849B1 (en) *	1998-10-13	2002-10-08	Novozymes, A/S	Modified polypeptide
US6403312B1 (en)	1998-10-16	2002-06-11	Xencor	Protein design automatic for protein libraries
US6686164B1 (en) *	1998-10-30	2004-02-03	Novozymes A/S	Low allergenic protein variants
AU772153B2 (en) *	1999-02-12	2004-04-08	Molecular Insight Pharmaceuticals, Inc.	Matrices for drug delivery and methods for making and using the same
CA2393688A1 (en) *	1999-12-09	2001-06-14	Chiron Corporation	Method for administering a cytokine to the central nervous system and the lymphatic system
US6586398B1 (en) *	2000-04-07	2003-07-01	Amgen, Inc.	Chemically modified novel erythropoietin stimulating protein compositions and methods
EP1280924A2 (en) *	2000-04-14	2003-02-05	University of South Carolina Research Foundation	Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses
US6967097B2 (en) *	2000-07-24	2005-11-22	Pcbu Services, Inc.	Phenylalainine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
CA2417185A1 (en) *	2000-07-25	2002-01-31	Shui-On Leung	Multivalent target binding protein
AU2001294774A1 (en) *	2000-09-26	2002-04-08	The Regents Of The University Of California	Characterization of phenylalanine ammonia-lyase (pal) gene in wounded lettuce
CA2428114C (en) *	2000-11-10	2013-07-23	Proteopharma Aps	Apolipoprotein analogues
KR20040088538A (ko)	2002-02-26	2004-10-16	이 아이 듀폰 디 네모아 앤드 캄파니	유전 인자의 재조합 방법
WO2004007538A2 (en) *	2002-07-17	2004-01-22	Cytos Biotechnology Ag	Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
CA2506026A1 (en)	2002-11-14	2004-05-27	The Scripps Research Institute	Crystalline form of fatty acid amine hydrolase (faah)
MXPA05013509A (es) *	2003-06-11	2006-04-05	Wyeth Corp	Polipeptidos de fusion de variante ib alfa de glucoproteina de plaquetas y metodos y uso de los mismos.
FR2868318B1 (fr) *	2004-04-01	2012-11-16	Commissariat Energie Atomique	Antigene tat stabilise et ses applications pour la vaccination anti-vih
US7670595B2 (en) *	2004-06-28	2010-03-02	Merck Patent Gmbh	Fc-interferon-beta fusion proteins
AU2005286763A1 (en)	2004-09-17	2006-03-30	Biomarin Pharmaceutical, Inc.	Variants and chemically-modified variants of phenylalanine ammonia-lyase
CA2614769A1 (en) *	2005-03-10	2006-09-21	Verenium Corporation	Lyase enzymes, nucleic acids encoding them and methods for making and using them
US7534595B2 (en) *	2006-06-12	2009-05-19	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
WO2008069958A2 (en)	2006-12-01	2008-06-12	The Salk Institute For Biological Studies	Substrate switched ammonia lyases and mutases
US7537923B2 (en) *	2007-08-17	2009-05-26	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

2007
- 2007-05-25 US US11/807,227 patent/US7534595B2/en active Active
2008
- 2008-05-23 PE PE2008000889A patent/PE20090315A1/es active IP Right Grant
- 2008-05-23 AU AU2008263190A patent/AU2008263190B2/en active Active
- 2008-05-23 PL PL08754717T patent/PL2152868T3/pl unknown
- 2008-05-23 EP EP13169362.4A patent/EP2657335A1/en not_active Withdrawn
- 2008-05-23 MY MYPI20094868 patent/MY151413A/en unknown
- 2008-05-23 HR HRP20151268TT patent/HRP20151268T1/hr unknown
- 2008-05-23 CN CN200880016898.4A patent/CN101842482B/zh active Active
- 2008-05-23 SI SI200831540T patent/SI2152868T1/sl unknown
- 2008-05-23 TW TW097119178A patent/TWI418633B/zh active
- 2008-05-23 ES ES08754717.0T patent/ES2551315T3/es active Active
- 2008-05-23 JP JP2010509405A patent/JP5670183B2/ja active Active
- 2008-05-23 EA EA200970980A patent/EA018443B1/ru unknown
- 2008-05-23 CL CL2008001497A patent/CL2008001497A1/es unknown
- 2008-05-23 KR KR20157007821A patent/KR20150038753A/ko not_active Ceased
- 2008-05-23 MX MX2009012453A patent/MX2009012453A/es active IP Right Grant
- 2008-05-23 PT PT87547170T patent/PT2152868E/pt unknown
- 2008-05-23 DK DK08754717.0T patent/DK2152868T3/en active
- 2008-05-23 KR KR1020097027018A patent/KR101603796B1/ko active Active
- 2008-05-23 CA CA2687450A patent/CA2687450C/en active Active
- 2008-05-23 WO PCT/US2008/006661 patent/WO2008153776A1/en not_active Ceased
- 2008-05-23 EP EP08754717.0A patent/EP2152868B1/en active Active
- 2008-05-23 BR BRPI0811267A patent/BRPI0811267B8/pt active IP Right Grant
- 2008-05-23 AR ARP080102198A patent/AR066716A1/es active IP Right Grant
- 2008-05-23 HU HUE08754717A patent/HUE025784T2/en unknown
2009
- 2009-11-15 IL IL202132A patent/IL202132A/en active IP Right Grant
2015
- 2015-11-06 CY CY20151100997T patent/CY1116894T1/el unknown
2018
- 2018-01-17 AR ARP180100106A patent/AR110834A2/es unknown
2019
- 2019-10-09 NL NL301011C patent/NL301011I2/nl unknown
- 2019-10-10 LT LTPA2019517C patent/LTC2152868I2/lt unknown
- 2019-10-14 LU LU00133C patent/LUC00133I2/fr unknown
- 2019-10-16 NO NO2019037C patent/NO2019037I1/no unknown
- 2019-10-17 CY CY2019039C patent/CY2019039I1/el unknown
- 2019-10-18 HU HUS1900049C patent/HUS1900049I1/hu unknown

Also Published As

Publication number	Publication date
NL301011I1 (nl)	2019-10-16
CL2008001497A1 (es)	2009-01-09
ES2551315T3 (es)	2015-11-18
TWI418633B (zh)	2013-12-11
CY2019039I2 (el)	2020-05-29
HRP20151268T1 (hr)	2015-12-18
CY1116894T1 (el)	2017-04-05
CN101842482B (zh)	2014-10-22
KR20150038753A (ko)	2015-04-08
AU2008263190A1 (en)	2008-12-18
TW200902052A (en)	2009-01-16
NO2019037I1 (no)	2019-10-16
IL202132A (en)	2017-06-29
IL202132A0 (en)	2010-06-16
MY151413A (en)	2014-05-30
CY2019039I1 (el)	2020-05-29
BRPI0811267B1 (pt)	2020-11-10
KR20100024437A (ko)	2010-03-05
MX2009012453A (es)	2010-01-25
EP2152868A1 (en)	2010-02-17
JP2010529835A (ja)	2010-09-02
EA200970980A1 (ru)	2010-04-30
WO2008153776A8 (en)	2009-07-30
LUC00133I2 (sl)	2020-07-16
EA018443B1 (ru)	2013-08-30
CA2687450C (en)	2019-03-26
DK2152868T3 (en)	2015-11-16
HUE025784T2 (en)	2016-05-30
CN101842482A (zh)	2010-09-22
LTPA2019517I1 (lt)	2019-10-25
HUS1900049I1 (hu)	2019-11-28
JP5670183B2 (ja)	2015-02-18
LUC00133I1 (sl)	2019-10-16
EP2152868B1 (en)	2015-09-02
US20080008695A1 (en)	2008-01-10
PL2152868T3 (pl)	2016-01-29
BRPI0811267A2 (pt)	2014-10-07
NL301011I2 (nl)	2020-05-13
CA2687450A1 (en)	2008-12-18
BRPI0811267B8 (pt)	2021-05-25
PT2152868E (pt)	2015-11-13
WO2008153776A1 (en)	2008-12-18
US7534595B2 (en)	2009-05-19
AU2008263190B2 (en)	2014-04-17
EP2657335A1 (en)	2013-10-30
AR066716A1 (es)	2009-09-09
KR101603796B1 (ko)	2016-03-17
AR110834A2 (es)	2019-05-08
PE20090315A1 (es)	2009-03-19
HK1135141A1 (zh)	2010-05-28
LTC2152868I2 (lt)	2020-09-25

Publication	Publication Date	Title
HUS1900049I1 (hu)	2019-11-28	Prokarióta fenilalanin ammónia-liáz készítmények és azok alkalmazási eljárásai
HUE029510T2 (hu)	2017-02-28	Prokariota fenilalanin ammónia-liáz kompozíciók, valamint eljárás rák kezelésére az ezekbõl származó készítményekkel
IL257437B (en)	2019-06-30	Compositions of prokaryotic phenylalanine ammonia lyase variants and methods of using the compositions
ZA201001300B (en)	2010-11-24	Antigen-asjuvant compositions and methods
PT2101766T (pt)	2016-12-28	Composições e métodos de utilização de (r)-pramipexole
AP2646A (en)	2013-04-17	Peptide sequences and compositions
IL195619A0 (en)	2009-09-01	Compositions and methods for joininig non-conjoined iumens
HRP20160902T1 (hr)	2016-09-23	Pripravci i postupci uporabe forbolskih estera
GB0717864D0 (en)	2007-10-24	Peptide sequences and compositions
EP2101731A4 (en)	2011-04-20	PROCESSES AND COMPOSITIONS WITH END OXIFES
PL2101766T3 (pl)	2017-04-28	Kompozycje i sposoby stosowania (R)-pramipeksolu
IL238404A0 (en)	2015-06-30	Preparations and methods to prevent influenza
GB0721291D0 (en)	2007-12-12	Methods and compositions
GB0719526D0 (en)	2007-11-14	Compositions and methods
GB0605247D0 (en)	2006-04-26	Compositions and methods for immunisation
GB0617171D0 (en)	2006-10-11	Novel compositions and methods
ZA201004894B (en)	2011-05-25	Nuctraceutical composition and methods of use
ZA201004893B (en)	2011-05-25	Nuctraceutical composition and methods of use
GB0724549D0 (en)	2008-01-30	Compositions and methods
GB0717683D0 (en)	2007-10-17	Compositions and methods
GB0723775D0 (en)	2008-01-16	Methods and compositions
GB0616269D0 (en)	2006-09-27	Methods and compositions
GB0625230D0 (en)	2007-01-24	Compositions and methods
GB0607565D0 (en)	2006-05-24	Methods and compositions
HK1143743A (en)	2011-01-14	Peptide sequences and compositions